Evidence map›Paper›PMID 41286288›Full record

ArticleScientific reports2025

WA-NET: enhanced boundary-aware segmentation of skin lesions via frequency-spatial feature fusion and attention-guided edge refinement.

Gefeng Hu, Wen Zhu, Xinyi Liao, Qingbo Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gefeng HuCollege of Mathematics and Statistics, Hainan Normal University, Haikou, 571158, China.
Wen ZhuCollege of Mathematics and Statistics, Hainan Normal University, Haikou, 571158, China. syzhuwen@163.com.
Xinyi LiaoChina Unicom (Hainan) Industrial Internet Co., Ltd, Haikou, 571924, China.
Qingbo LiCollege of Mathematics and Statistics, Hainan Normal University, Haikou, 571158, China.

Funding

National Key R and D Program of China 2020YFB2104400National Natural Science Foundation of China 62362027
6 · The paper itself

Abstract

Skin cancer remains a major public health concern due to its high morbidity and mortality rates. While automatic segmentation techniques have improved diagnostic accuracy, they continue to face challenges such as artefacts, small lesion detection, and poor contrast between lesions and surrounding tissue. To overcome these limitations, we propose WA-NET, a novel skin lesion segmentation network that integrates a Boundary Refinement module (BRM) and an Enhanced Wavelet Transform (EWT) module. The BRM employs independent edge detection branches to enhance boundary representation, particularly in low-contrast regions. The EWT module adaptively fuses multi-scale, multi-directional sub-band features in the frequency domain to better capture texture and structural details. Furthermore, a composite loss function combining binary cross-entropy, Dice loss, and edge-supervised loss is introduced to improve both global segmentation accuracy and local boundary precision. WA-NET achieves state-of-the-art performance on three benchmark datasets-ISIC2017 (DSC: 0.9395, SE: 0.9357, ACC: 0.9573), ISIC2018 (DSC: 0.9458, SE: 0.9460, ACC: 0.9610), and PH2 (DSC: 0.9517, SE: 0.9593, ACC: 0.9638)-demonstrating strong robustness and superior boundary segmentation under challenging imaging conditions.

Indexed as

Image Interpretation, Computer-AssistedImage Processing, Computer-AssistedSkinSkin NeoplasmsAlgorithmsHumansNeural Networks, ComputerWavelet AnalysisBoundary refinementDeep learningMedical image SegmentationSkin lesion segmentation

Identifiers

PMID41286288
PMCPMC12644593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.